Join us on October 29, 2018, from 1:30 - 5:30 pm MT at The Scottsdale Resort at McCormick Ranch in Scottsdale, Arizona for the 15th International Symposium post-conference workshops.
- Early Bird Rate - $120
- Standard Rate - $170
- Onsite Rate - $230
Can't join us for the entire conference? This year post-conference workshops are available without full conference registration.
Attendees will be able to select one four-hour workshop from the following options:
Therapeutic Yoga in Cancer Patients: Research Methodology and Clinical Application
- Santosh Rao, MD, Banner MD Anderson
- Lorenzo Cohen, PhD, MD Anderson Cancer Center
- Raghavendra Rao, PhD, Bangalore Institute of Oncology, India
- Johanne Lauktein, Holistic Health Instructor, Banner MD Anderson
Therapeutic yoga has been studied for its use in symptom management, including fatigue and stress reduction, in oncology. However, there are broad definitions for what constitutes therapeutic yoga, with different styles, teachers or schools, and timings adding to the variability. Yoga, within the context of oncology, requires a focused approach guiding patients relative to personal limitations and therapeutic complexities.
Collaborative research with Indian researchers, who have focused attention on the use of yoga in oncology, could spur efforts to utilize the best research methodology and innovations in yoga implementation. Some of this work has been underway through alliances between the University of Texas, MD Anderson Cancer Center and Vivekananda Kendra (S-VYASA Yoga University) in Bangalore, India. Leaders in India on yoga research are now turning their attention towards focused outcomes using yoga, both evaluating symptom palliation and clinical outcomes. Part of this work includes evaluations of biomarkers and epigenetic modifications.
Finally, the clinical applications of yoga within oncology should be discussed further; how should yoga instructors be trained, and what are some of the concerns or issues that may occur with cancer-yoga programs? As our experience grows within a clinical context in the modern age of clinical research, the discussion of how to use yoga is ongoing and very important.
This session will include an interactive yoga component.
Integrative Pain Management in Oncology: Psychophysiological, Cultural & Global Models of Care
- Judith M. Fouladbakhsh, PhD, RN, AHN-BC, PHCNS-BC, CHTP, Oakland University
- Judith Lacey, MBBS, FRACGPm FAChPM, Chris O'Brien Lifehouse Cancer Centre, New South Wales, Australia
- Yair Maimon, OMD, PhD, AC, Sheba Medical Center, Tel Hashomer, Israel
- Jonathan Ammen, M.Ed., M.Cc, Lic.Ac, Lahey Hospital and Medical Center, Burlington, Massachusetts
- Kathleen Sanders, FNP-BC, MPH, Seattle Cancer Care Alliance/Fred Hutchinson/UW Consortium, Seattle, Washington
- Deirdre Wallace-Steel, BSN, BA, RN, RYT, St. John's Hospital, Detroit, Michigan
Analysis of the continuing high prevalence of cancer pain, changes in pain management protocols due to the opioid epidemic, increasing cultural diversity in patient populations, and the critical need to understand psychological and cultural factors which influence the pain experience will be discussed, addressing gaps in care and highlighting the relevance to integrative oncology. Global models of integrative pain management will be explored to provide insight on ways to incorporate evidence-based approaches into the patient plan of care. Presenters cover A wide-range of expertise on pain management theory, research and clinical practice across multiple disciplines and regions of the world.
The goal of this workshop is to expand knowledge of cancer pain psychophysiology, and culturally appropriate and collaborative models for integrative pain management from a global perspective.
Topics for presentation and discussion include:
- Pain: What does it mean?
- Psychophysiological pathways & theories of pain
- Influence of cultures across the globe on the pain experience
- Current pain treatment strategies & psychosocial dilemmas (opioid crisis; symptom clusters)
- Influence of biomedical, cultural and traditional healing practices on cancer pain management
- Perception & meaning of cancer pain: Patient & provider perspectives
- Pain self-treatment: What are our patients doing?
- Traditional Healing Systems: Overview of the evidence and practical approaches
- Traditional Chinese Medicine
- Ayurvedic Medicine
- Energy Medicine
- Naturopathic Medicine
- Integrative pain management models: Oncology
- Philosophy: Incorporating cross-cultural, psychosocial perspectives
- Theory: blending evidence-based approaches for holistic person-centered care
- Approaches: Using interprofessional teams with equalized/shared decision-making
- Clinical Models: Integrative pain management for cancer patients across the globe
- North America
- Asia [Israel, India, China]
Traditional Chinese Medicine or Integrative Oncology for GI Cancer: An U.S.-China Conversation, Season 2
- Yufei Yang, MD, Xiyuan Hospital, China Academy of Chinese Medical Sciences, China
- Haibo Cheng, MD, Nanjing University of Traditional Chinese Medicine, China
- Haibo Zhang, MD, Guangdong Traditional Chinese Medicine Hospital, China
- Wenli Liu, MD, MD Anderson Cancer Center
- Yun Xu, MD, PhD. Xiyuan Hospital, China Academy of Chinese Medical Science
- Peng Shu , Jiangsu TCM Hospital
- Aiguang Zhao , Longhua Hospital of Shanghai TCM University
- Ping Wang, Xiyuan Hospital, China Academy of Chinese Medical Science
Gastrointestinal(GI) cancer alone accounts for one in five global cancer burden. In China, over 80% of Chinese cancer patients have ever used Traditional Chinese Medicine (TCM) during or after GI cancer treatments. As part of complementary and alternative medicine (CAM), TCM treatments including acupuncture, herbs, Tuina are also arousing more and more interests among US cancer patients and caregivers, especially for GI cancer which is highly related to lifestyle. Although there are still limited evidence on TCM’s efficacy in cancer treatment and survival outcome, existing studies have shown that TCM could help improve some cancer survivors’ quality of life and relieve certain symptoms such as fatigue. So far, there are expanding research on TCM and GI cancer, from prevention to treatment. For example, the proposed organizer of the workshop is currently being supported by the China National Key Research Program of TCM modernization, including six large sample size RCT trials on TCM and GI cancer.
However, there are still many differences between clinical TCM practice in China and integrative oncology practice in the US. For example, in China, 90% of Chinese patients use herbal medicine, while only less than 10% use acupuncture. Further, most TCM treatments are covered by major medical insurance system in China; while currently only cover few TCM therapies are covered by US medical insurance. In China, all TCM physicians have at least 5-year medical school education where both Chinese medicine and western medicine courses are given; while in US CAM are mostly performed by therapists. Because of these different situations and practice models, a conversation between both sides is very important and novel for a better understanding of personalized TCM treatments for cancer care among US clinicians. Last year, we held a workshop comparing four cases of colorectal cancer and breast cancer from China and the US respectively and introduced TCM and integrative oncology interventions for those cases from both sides. This workshop had received much favorable comment by SIO participants and committees.
This workshop is continued conversation and discussion of the SIO2017 workshop that compared four cases of colorectal cancer and breast cancer from China and the US and introduced TCM and integrative oncology interventions for those cases from both sides. Attendees do not need to have attended last year in order to participate in this workshop.